Executive Order 14293 Act of 2025
Sponsored By: Representative Burchett, Tim [R-TN-2]
Introduced
Summary
Gives Executive Order 14293 the force of law. The bill codifies Executive Order 14293, which relates to regulatory relief to promote domestic production of critical medicines, and elevates the Order's regulatory-relief provisions to binding statutory law for federal agencies.
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
Analyzed Economic Effects
1 provisions identified: 1 benefits, 0 costs, 0 mixed.
Make medicine production relief law
This bill would make Executive Order 14293 (90 Fed. Reg. 19615) into law. It relates to regulatory relief to boost U.S. production of critical medicines. Federal agencies that oversee drug manufacturing would need to carry out the order’s relief rules. If enacted, it would take effect upon enactment. There are no new payments, taxes, or funding in this bill. Households could see indirect effects, like a more stable supply of medicines.
Sponsors & CoSponsors
Sponsor
Burchett, Tim [R-TN-2]
TN • R
Cosponsors
Rep. Luna, Anna Paulina [R-FL-13]
FL • R
Sponsored 6/3/2025
Roll Call Votes
No roll call votes available for this bill.
View on Congress.gov